Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stefano Guadagni
MGMT Methylation Correlates With Melphalan Pelvic Perfusion Survival in Stage III Melanoma Patients
Melanoma Research
Dermatology
Cancer Research
Oncology
Related publications
Methylation of MGMT Is Associated With Poor Prognosis in Patients With Stage III Duodenal Adenocarcinoma
PLoS ONE
Multidisciplinary
Review of Regional Limb Perfusion With Melphalan for Malignant Melanoma
BMJ
Melphalan Tissue Concentrations in Patients Treated With Regional Isolated Perfusion for Melanoma of the Lower Limb
British Journal of Cancer
Cancer Research
Oncology
Preoperative BRAF Inhibition in Patients With Irresectable Locally Advanced Stage III Melanoma
Melanoma Management
Dermatology
Oncology
Twelve-Year Survival and Immune Correlates in Dendritic Cell–vaccinated Melanoma Patients
JCI insight
Medicine
Low Levels of Quantified MGMT Methylation Status Impart Positive Impact on Survival
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Antibody Response to Melanoma Helper-Peptide Vaccine Correlates With Survival
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients With In-Transit Melanoma Metastases Treated With Isolated Limb Perfusion
Annals of Surgical Oncology
Oncology
Surgery
Chemosaturation With Percutaneous Hepatic Perfusion of Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A Single Center Experience
Cancer Imaging
Nuclear Medicine
Radiology
Ultrasound Technology
Oncology
Radiological
Imaging
Medicine
